Food and Drug Administration, HHS.
Direct final rule; withdrawal.
The Food and Drug Administration (FDA) published in the Federal Register of April 1, 2010, a direct final rule that was intended to make noncontroversial amendments to existing regulations which would require the submission of readily available pediatric medical device information as a part of premarket approval applications, requests for humanitarian use device exemptions, and any product development protocols. The comment period closed on June 15, 2010. FDA is withdrawing the direct final rule because the agency received significant adverse comment.
The direct final rule published at 75 FR 16347, April 1, 2010, is withdrawn on July 19, 2010.Start Further Info
FOR FURTHER INFORMATION CONTACT:
Robert Gatling, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 1640, Silver Spring, MD 20993, 301-796-6560.End Further Info
Therefore, under the Federal Food, Drug, and Cosmetic Act, and under authority delegated to the Commissioner of Food and Drugs, the direct final rule published on April 1, 2010, at 75 FR 16347 is withdrawn.Start Signature
Dated: July 9, 2010.
Acting Assistant Commissioner for Policy.
[FR Doc. 2010-17617 Filed 7-19-10; 8:45 am]
BILLING CODE 4160-01-S